BCL2 and breast cancer: However, another meta-analysis from 2013, in which 23 studies involving almost 2,500 BC patients, showed that negative BCL-2 expression was associated with pathological complete response in women treated with ATC-based neoadjuvant chemotherapy (Yang et al. 2013).